You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股异动 | 东方生物涨近9% 拟以5亿元投建东方基因国际研发创新中心项目 上年净利同比增近2倍
格隆汇 02-28 10:44
格隆汇2月28日丨东方生物(688298.SH)涨8.96%,报256.06元,总市值307亿元。东方生物26日发布业绩快报,2021年营业收入为100.32亿元,同比增长207.22%;归母净利47.77亿元,同比增长184.80%;基本每股收益39.81元。2021年公司新型冠状病毒抗原快速检测试剂(含家庭自测)继续投入到防疫事业中,产品在欧洲市场销售业绩继续大幅度增长,常规诊断试剂、诊断仪器业务保持稳定发展,促使2021年度经营业绩大幅度增长。同日公吿,拟在上海市临港新片区投资设立公司全资子公司,建设“东方基因国际研发创新中心项目”,项目投资总额5亿元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account